Candel Therapeutics candeltx.com


Public lists: Cancer Therapeutics (1146)

Candel Therapeutics is a Massachusetts based biotechnology company developing its proprietary immuno-oncology platforms, including its Gene Mediated Cytotoxic Immunotherapy platform and rQNestin34.5 platform, for the treatment of solid tumors.

Candel Therapeutics is a Massachusetts based biotechnology company developing its proprietary immuno-oncology platforms, including its Gene Mediated Cytotoxic Immunotherapy platform and rQNestin34.5 platform, for the treatment of solid tumors.

Company (Alive / Active)

Phone: (617) 916-5445

Fax:

440 Lexington Avenue

Auburndale, 02466
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Candel Therapeutics $51.2M Apr 1, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Candel Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)